Chipiron has raised over $22 million in total funding since its inception, with plans for clinical trials in 2026.
Founders
Evan Kervella
Company Description
Chipiron aims to make MRI as accessible as X-ray, developing a miniaturized MRI scanner that is compact, mobile, and inclusive for patients with implants or those who are claustrophobic, obese, or restless.